Dr. Prerona Boruah: Research Director at Association of Ayushinventors, India
Title/Designation: Dr
Name: Prerona Boruah
Current Role/Designation: Research Director
Organization/Institution: Association of Ayushinventors, India
Subject Track: Pharmacology
Key Areas of Expertise: Cancer Immunology
Award Category: Innovative Researcher Award
Dr. Prerona Boruah is a highly skilled immunologist with a Ph.D. in Immunology and more than seven years of experience spanning academic research, biotech industry projects, and translational oncology initiatives. Her expertise covers the full spectrum from molecular assays and preclinical model development to regulatory submissions and stakeholder coordination. Having worked across India, China, and now the Netherlands, she has developed a versatile scientific and managerial profile, bringing together strong laboratory experience, protocol and SOP development, clinical study coordination, and leadership in multidisciplinary teams. She is now pivoting into translational oncology, where she is motivated to apply her immunology background to biomarker discovery, liquid biopsy studies, and colorectal cancer research.
Online Profiles
Publication Metrics
Her publications have collectively earned 273 citations, with an h-index of 6 and an i10-index of 5, reflecting her impact in immunology and oncology research through both original articles and reviews.
Education
She earned her Ph.D. in Immunology from the Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, in 2019. Her doctoral research explored the role of Interleukin-34 (IL-34) in Japanese Encephalitis Virus infection, using both neuronal cell culture and knockout mouse models. Before this, she obtained her Master of Science in Biotechnology from North Eastern Hill University, India, in 2015, where she built her foundation in molecular biology and immunological techniques. Her academic journey began with a Bachelor of Science in Biotechnology from St. Anthony’s College, Shillong, India, in 2013, which inspired her transition into advanced biomedical sciences and translational medicine.
Research Focus
Dr. Boruah’s research interests bridge fundamental immunology and applied oncology. She is particularly focused on translating discoveries from cytokine biology and immune cell signaling into practical cancer therapeutics and diagnostics. Her work covers biomarker discovery, preclinical disease models, cancer immunology, antibody therapeutics, and molecular assays. With increasing emphasis on clinical relevance, she is building expertise in coordinating liquid biopsy and ctDNA studies for colorectal cancer, aiming to translate biomarker findings into meaningful clinical impact. She is equally engaged in regulatory science, documentation, and SOP development, which enables her to integrate scientific innovation with compliance and implementation in clinical and industrial settings.
Experience
Currently serving as Research Director at the Association Ayush Inventors, Dr. Boruah leads the coordination of non-clinical testing projects, standardizes SOPs, and ensures data traceability for intellectual property and regulatory purposes. From 2022 to 2024, she was Principal Investigator at Padmashree Dr. D.Y. Patil Deemed to be University, where she directed therapeutic studies, authored protocols, won grants, and supervised students while driving immunology and oncology research. Earlier, she worked at Zhejiang Wolwo Biopharmaceuticals in Shanghai as a Project Lead and Drug Regulation Specialist, designing preclinical study protocols, preparing FDA/NMPA/CDSCO submissions, and contributing to GLP/GMP and QMS systems. Her scientific career began as a Ph.D. researcher at the Shanghai Veterinary Research Institute, where she investigated viral immunopathogenesis and authored several SCI publications.
Research Timeline & Activities
Between 2016 and 2019, Dr. Boruah pursued her Ph.D. in China, focusing on cytokine IL-34 and its role in viral pathogenesis. This phase gave her significant exposure to molecular and cellular techniques as well as animal models. From 2019 to 2022, she entered the biotech sector in Shanghai, where she led translational projects and contributed to high-stakes regulatory submissions. Returning to India in 2022, she transitioned into academic leadership as a Principal Investigator, securing grants and mentoring a new generation of students. Since 2024, she has been serving as Research Director in a global role with Association Ayush Inventors, coordinating multidisciplinary research, consolidating outputs into publications and patents, and driving translational innovation at the interface of academia, biotech, and clinical application.
Awards & Honors
Dr. Boruah’s contributions have been recognized through successful external research grants, her appointment to leadership positions in academic and research organizations, and her role as co-inventor on two patent applications filed in India in 2024 and 2025. These patents cover an antidiabetic extract and a phytomolecular anti-cancer extract formulation, reflecting her drive to translate laboratory discoveries into practical therapeutic solutions. She has also been acknowledged for her contributions to manuscript authoring, regulatory submissions, and her ability to bridge diverse research environments across multiple countries.
Top Noted Publication
Among her body of publications, one particularly notable work is her review article “Interleukin-34 in Disease Progressions: A Comprehensive Review” published in Critical Reviews in Immunology (2023). This paper synthesizes the current understanding of IL-34 in various diseases, including cancer and infectious diseases, and has become a reference point for researchers working on cytokine biology. In addition, her recent works in 2024 and 2025 on cancer therapeutics and natural product-based interventions demonstrate her expanding contributions to translational oncology and biomarker research.
-
Toxicological Consequences of Titanium Dioxide Nanoparticles (TiO₂NPs) and Their Jeopardy to Human Population
S. Shabbir, M.F.A. Kulyar, Z.A. Bhutta, P. Boruah, M. Asif
Bionanoscience 11 (2), 621–632, 2021
Citations: 126 -
The emerged genotype I of Japanese encephalitis virus shows an infectivity similar to genotype III in Culex pipiens mosquitoes from China
M. Hameed, K. Liu, M.N. Anwar, A. Wahaab, A. Safdar, D. Di, P. Boruah, J. Xu, …
PLoS Neglected Tropical Diseases 13 (9), e0007716, 2019
Citations: 36 -
Genome-wide transcriptome profiling uncovers differential miRNAs and lncRNAs in ovaries of Hu sheep at different developmental stages
S. Shabbir, P. Boruah, L. Xie, M.F.A. Kulyar, M. Nawaz, S. Yousuf, T. Liu, …
Scientific Reports 11 (1), 5865, 2021
Citations: 32 -
Cotton fabric loaded with ZnO nanoflowers as a photocatalytic reactor with promising antibacterial activity against pathogenic E. coli
A. Ashar, Z.A. Bhutta, M. Shoaib, N.K. Alharbi, M. Fakhar-e-Alam, M. Atif, …
Arabian Journal of Chemistry 16 (9), 105084, 2023
Citations: 30 -
Evaluation of hematological, antioxidant enzymes and oxidative stress parameters in buffaloes infected with babesiosis
Z.A. Bhutta, M.F.A. Kulyar, I.S. Jahanzaib, S. Shabbir, P. Boruah, A. Bello
Continental Vet J 2 (1), 29–34, 2022
Citations: 22
Strengths for the Innovative Researcher Award
1. Translational and Multidisciplinary Expertise
Dr. Boruah seamlessly integrates fundamental immunology with applied oncology, demonstrating a unique ability to translate laboratory discoveries into clinically relevant outcomes. Her work spans cytokine biology, immune cell signaling, biomarker discovery, and liquid biopsy studies, reflecting a comprehensive understanding of both basic science and translational research. This multidisciplinary approach enables her to bridge the gap between preclinical models and therapeutic applications, making her contributions highly innovative and impactful.
2. Global Research Experience and Leadership
Having worked across India, China, and the Netherlands, Dr. Boruah brings a versatile international perspective to research coordination and scientific problem-solving. She has led multidisciplinary teams in academia and industry, supervising students, managing projects, standardizing SOPs, and ensuring regulatory compliance. Her global exposure enhances collaboration, knowledge transfer, and adoption of best practices across diverse research environments.
3. Proficiency in Regulatory and Translational Science
Dr. Boruah has extensive experience in regulatory submissions, preclinical study design, and GLP/GMP compliance, making her adept at navigating the complexities of translational research. She has successfully contributed to FDA, NMPA, and CDSCO submissions, demonstrating her capacity to align innovative research with regulatory and intellectual property standards—a critical skill for turning scientific insights into real-world applications.
4. Strong Scientific Contributions and Impact
With 273 citations, an h-index of 6, and multiple notable publications, Dr. Boruah has established herself as a thought leader in immunology and translational oncology. Her publications cover viral immunopathogenesis, cytokine biology, nanotoxicology, and cancer therapeutics, highlighting her ability to produce high-quality, impactful research. Her review on IL-34 in Critical Reviews in Immunology has become a key reference in the field, underscoring her influence in advancing scientific knowledge.
5. Innovation and Intellectual Property
Dr. Boruah is a co-inventor on two patents filed in India (2024–2025) for an antidiabetic extract and a phytomolecular anti-cancer formulation, demonstrating her drive to translate scientific discoveries into practical therapeutic solutions. Her work exemplifies innovation not just in research methodology but also in developing commercially viable interventions, making her a strong candidate for recognition as an innovative researcher.